Table 6.
CD | |||||
N total = 378 | n | Response (%) | Unadjusted Odds Ratio (95%CI) | Adjusted Odds Ratio (95%CI) | P |
Female/male | 190/188 | 154 (81)/144 (77) | 1.31 (0.80-2.15) | 1.35 (0.79-2.30) | 0.270 |
Age at ePQ completion | 196/182 | 156 (80)/142 (78) | 1.10 (0.67-1.80) | 1.34 (0.79-2.30) | 0.281 |
>40/≤40 yr | |||||
Flare/no flare1 | 34/344 | 33 (97)/265 (77) | 9.84 (1.32-73.1) | 10.9 (1.43-82.4) | 0.021 |
Ileo colon/upper | 136/20 | 110 (81)/16 (80) | 1.06 (0.33-3.42) | 0.91 (0.26-3.19) | 0.879 |
Ileum/upper | 54/20 | 41 (76)/16 (80) | 0.79 (0.22-2.78) | 0.95 (0.27-3.35) | 0.631 |
Colon/upper | 153/20 | 122 (80)/16 (80) | 0.98 (0.31-3.15) | 0.71 (0.18-2.77) | 0.622 |
Unknown/upper | 15/20 | 9 (60)/16 (80) | 0.38 (0.083-1.69) | 0.38 (0.075-1.90) | 0.237 |
Flare within 3 mo period previous of the moment of ePQ completion. n: number of patients; CI: confidence interval; Upper: esophagus and/or stomach and/or duodenum and/or jejunum; Unknown: unknown disease location.